Teva Pharmaceutics USA acquires three buildings for an R&D campus in West Chester - Philadelphia Business Journal
Teva's Share of the US Generics Market Could Boost Its Stock
Teva Pharmaceuticals - Wikipedia
Teva Pharmaceuticals - Wikipedia
Teva shares surge on corporate shake-up - MarketWatch
Attorney general sues Teva Pharmaceuticals for alleged price fixing
Teva selects North Jersey site for its new North American headquarters. - Philadelphia Business Journal
Teva Pharmaceutical Industries Ltd. - Find out what Janet Vaughn, Teva VP for Regulatory Affairs, North America Generics, has learned from life's challenges. https://bit.ly/3C558u3 | Facebook
Teva makes changes to North American leadership, other executive management roles | ROI-NJ
Rene Sly DeSimone - Director North America Insights - Teva Pharmaceuticals | LinkedIn
Teva's (NYSE: TEVA) move of North American HQ to N.J. takes another step forward - Philadelphia Business Journal
Teva: Warren Buffett Likely Made A Mistake Selling Shares | Seeking Alpha
Teva profit plummets, stock slides | Ctech
Teva Announces New Organization Structure and Leadership Changes | Business Wire
A logo sign outside of a facility operated by Teva Pharmaceutical Industries in North Wales, Pennsylvania Stock Photo - Alamy
Teva Pharmaceuticals Office Photos | Glassdoor
Lured by $40 million tax break, Teva moving U.S. headquarters from Pa. to North Jersey - WHYY
Teva & Barr Get Super-Sized
A map of the British Empire in North America - Maps at the Tennessee State Library & Archives - Tennessee Virtual Archive
Teva restructuring hits American HQ, claiming 200-plus Pennsylvania jobs | Fierce Pharma
Teva issues in line guidance as North American revenue remains flat (NYSE: TEVA) | Seeking Alpha
Sven Dethlefs - EVP, North America Commercial at SICOR Inc. | The Org
Teva, amid massive restructuring, closes in on $3B cost-cutting goal | Fierce Pharma
Teva Announces New Brand Positioning and Visual Identity in North America
Teva Pharmaceuticals on Twitter: "At a recent FDA public meeting, Teva's VP of Regulatory Affairs for Generics in North America, Scott Tomsky, called for a more flexible and innovative approach to generic